SECdecoded › REGN
REGENERON PHARMACEUTICALS, INC. (REGN) recent events (8-K)
| 2026-07-06 | 2.02 Earnings release / quarterly results | SEC.gov → |
| 2026-06-17 | 5.07 Shareholder vote results | SEC.gov → |
| 2026-04-29 | 2.02 Earnings release / quarterly results 9.01 Financial statements and exhibits |
SEC.gov → |
| 2026-04-08 | 2.02 Earnings release / quarterly results | SEC.gov → |
| 2026-01-30 | 2.02 Earnings release / quarterly results 9.01 Financial statements and exhibits |
SEC.gov → |
| 2026-01-12 | 2.02 Earnings release / quarterly results 7.01 Investor-relations disclosure (Reg FD) 9.01 Financial statements and exhibits |
SEC.gov → |
| 2025-10-28 | 2.02 Earnings release / quarterly results 9.01 Financial statements and exhibits |
SEC.gov → |
| 2025-10-06 | 2.02 Earnings release / quarterly results | SEC.gov → |
| 2025-08-01 | 2.02 Earnings release / quarterly results 9.01 Financial statements and exhibits |
SEC.gov → |
| 2025-06-18 | 5.07 Shareholder vote results | SEC.gov → |
| 2025-04-29 | 2.02 Earnings release / quarterly results 9.01 Financial statements and exhibits |
SEC.gov → |
| 2025-02-04 | 2.02 Earnings release / quarterly results 8.01 Other notable event 9.01 Financial statements and exhibits |
SEC.gov → |
| 2025-01-13 | 2.02 Earnings release / quarterly results 7.01 Investor-relations disclosure (Reg FD) 9.01 Financial statements and exhibits |
SEC.gov → |
| 2024-10-31 | 2.02 Earnings release / quarterly results 9.01 Financial statements and exhibits |
SEC.gov → |
| 2024-10-07 | 2.02 Earnings release / quarterly results | SEC.gov → |
An 8-K is a "something material just happened" filing. Each item code above is decoded to plain English; the app explains what the event actually means for the company.
Every material event REGN is required to disclose, decoded — earnings, executive changes, acquisitions, and more.
Open REGN in SECdecoded → Free account · plain-English AI analysis · no card required